{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph.\n\nParagraph: The mutation changed the adrenodoxin cofactor binding residue 362Arg to 362Ser ( CGT 362Arg to AGT 362Ser ) , and was responsible for deficiency in the sterol 27 - hydroxylase activity , as confirmed by expression of mutant cDNA into COS - 1 cells .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! To identify the \"disease\" entities in the paragraph, we can break it down step by step:\n\n1. \"mutation\" - This is the first disease entity mentioned in the paragraph. It refers to a genetic change or alteration in the DNA sequence.\n2. \"adrenodoxin cofactor binding residue 362\" - This is the second disease entity mentioned. It refers to a specific location in the adrenodoxin protein where a genetic change occurred.\n3. \"362Arg to 362Ser\" - This is the specific genetic change that occurred at the adrenodoxin cofactor binding residue 362. It is a substitution of the amino acid arginine (Arg) with serine (Ser).\n4. \"deficiency in the sterol 27-hydroxylase activity\" - This is the third disease entity mentioned. It refers to a lack or abnormality in the function of the enzyme sterol 27-hydroxylase, which is caused by the genetic change in the adrenodoxin protein.\n5. \"COS-1 cells\" - This is the fourth disease entity mentioned. It refers to a specific type of cell line (COS-1) that was used in an experiment to study the effect of the genetic change on the function of the adrenodoxin protein.\n\nSo, the three disease entities mentioned in the paragraph are:\n\n1. Mutation\n2. Adrenodoxin cofactor binding residue 362\n3. Deficiency in sterol 27-hydroxylase activity\n4. COS-1 cells"},
    {"role": "user", "content": "Please remove irrelevant entities and only keep the entities that clearly refer to Disease."},
    {"role": "assistant", "content": "Of course! Here are the disease entities mentioned in the paragraph:\n\n1. Deficiency in sterol 27-hydroxylase activity\n\nThe other entities mentioned in the paragraph (mutation, adrenodoxin cofactor binding residue 362, and COS-1 cells) are not disease entities, so I have removed them from the list."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Certainly! Here are the disease entities mentioned in the paragraph:\n\n| Disease |\n| --- |\n| Deficiency in sterol 27-hydroxylase activity |\n\nI hope this helps! Let me know if you have any further questions."}
  ]
}